Eagle Pharmaceuticals to Present at Two Investor Conferences in June
Get Alerts EGRX Hot Sheet
Join SI Premium – FREE
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at two conferences in June.
At the Jefferies 2015 Annual Healthcare Conference, Eagle’s presentation is scheduled as follows:
|
• |
Date: |
Wednesday, June 3, 2015 |
|||
|
• |
Time: |
4:30 p.m. EDT |
|||
|
• |
Location: |
New York, NY |
|||
The following week, the Eagle presentation at the William Blair Growth Stock Conference is scheduled for:
|
• |
Date: |
Tuesday, June 9, 2015 |
|||
|
• |
Time: |
12:50 p.m. CDT / 1:50 p.m. EDT |
|||
|
• |
Location: |
Chicago, IL |
|||
Each presentation will be webcast live at the aforementioned times, and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150521005096/en/
In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President
Source: Eagle Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Appointment of Non-Executive Directors
- Solana Unchained Emerges as a Closely Watched Solana Presale Following Product Ecosystem Reveal
- AG.AL Crowned Esports World Cup 2026 Club Champion After Landmark Competition in Paris
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
William Blair, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share